BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29297907)

  • 21. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
    Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
    Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
    Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial appendage closure - new choice for no-option patients with atrial fibrillation.
    Grygier M; Olasinska-Wisniewska A; Trojnarska O; Lesiak M; Araszkiewicz A; Mularek-Kubzdela T; Grajek S
    Minerva Cardioangiol; 2015 Dec; 63(6):577-86. PubMed ID: 24743471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke].
    Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B
    Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic impact of percutaneous left atrial appendage closure in patients with paroxysmal atrial fibrillation.
    Asmarats L; Bernier M; O'Hara G; Paradis JM; O'Connor K; Beaudoin J; Bilodeau S; Cavalcanti R; Champagne J; Rodés-Cabau J
    J Interv Card Electrophysiol; 2018 Nov; 53(2):151-157. PubMed ID: 29869301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry.
    Lellouche N; Arrouasse R; Ternacle J; Gallet R; Hermida JS; Hamon D; Juliard JM; Pasquie JL; Dhanjal T; Teiger E; Le Corvoisier P
    BMC Cardiovasc Disord; 2021 May; 21(1):227. PubMed ID: 33941095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.
    Saw J; Fahmy P; DeJong P; Lempereur M; Spencer R; Tsang M; Gin K; Jue J; Mayo J; McLaughlin P; Nicolaou S
    Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1198-206. PubMed ID: 25851318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation.
    Regueiro A; Cruz-Gonzalez I; Bethencourt A; Nombela-Franco L; Champagne J; Asmarats L; Jiménez-Quevedo P; Rodriguez-Gabella T; Rama-Merchan JC; Puri R; O'Hara G; Rodés-Cabau J
    J Interv Card Electrophysiol; 2018 Jun; 52(1):53-59. PubMed ID: 29564664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of closed-chest ligation of the left atrial appendage in humans.
    Bartus K; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Yakubov SJ; Lee RJ
    Heart Rhythm; 2011 Feb; 8(2):188-93. PubMed ID: 21050893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study).
    Parikh V; Rasekh A; Mohanty S; Yarlagadda B; Atkins D; Bommana S; Turagam M; Jeffery C; Carroll H; Nydegger C; Jaeger M; Dar T; Cheng J; Gopinnathanair R; Dibiase L; Lee R; Horton R; Natale A; Lakkireddy D
    J Interv Card Electrophysiol; 2020 Apr; 57(3):409-416. PubMed ID: 31863251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and feasibility of combined atrial fibrillation ablation and left atrial appendage occlusion after left atrial appendage electrical isolation.
    Kita K; Carlson S; Huntsinger M; Tun H; Sohn J; Doshi RN
    J Interv Card Electrophysiol; 2020 Jan; 57(1):43-55. PubMed ID: 31377973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing Measurements of CT Angiography, TEE, and Fluoroscopy of the Left Atrial Appendage for Percutaneous Closure.
    Saw J; Fahmy P; Spencer R; Prakash R; McLaughlin P; Nicolaou S; Tsang M
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):414-22. PubMed ID: 26728988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy analysis of one-stop intervention for treating nonvalvular atrial fibrillation.
    Hu H; Cui K; Jiang J; Fu H; Zeng R
    Pacing Clin Electrophysiol; 2018 Jan; 41(1):28-34. PubMed ID: 29194654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias.
    Rillig A; Tilz RR; Lin T; Fink T; Heeger CH; Arya A; Metzner A; Mathew S; Wissner E; Makimoto H; Wohlmuth P; Kuck KH; Ouyang F
    Circ Arrhythm Electrophysiol; 2016 May; 9(5):e003461. PubMed ID: 27153877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
    Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.